BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9125203)

  • 1. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.
    Kim SN; Lee GR; Hwang ES; Lee JH; Park SD; Cho-Chung YS; Hong SH
    Biochem Biophys Res Commun; 1997 Mar; 232(2):469-73. PubMed ID: 9125203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
    Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
    J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
    Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
    Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental gene therapy of human colon cancer.
    Bold RJ; Warren RE; Ishizuka J; Cho-Chung YS; Townsend CM; Thompson JC
    Surgery; 1994 Aug; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS; Cho-Chung YS
    Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
    Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V
    Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
    Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O; Hacker NF; Cho-Chung YS
    Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells.
    Pepe S; Ruggiero A; Tortora G; Ciardiello F; Garbi C; Yokozaki H; Cho-Chung YS; Clair T; Skalhegg BS; Bianco AR
    Cytometry; 1994 Jan; 15(1):73-9. PubMed ID: 8162827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cAMP-dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells.
    Boundy VA; Chen J; Nestler EJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1058-65. PubMed ID: 9694969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.
    Tortora G; Pepe S; Cirafici AM; Ciardiello F; Porcellini A; Clair T; Colletta G; Cho-Chung YS; Bianco AR
    Cell Growth Differ; 1993 May; 4(5):359-65. PubMed ID: 8518230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants.
    Cvijic ME; Chin KV
    Cell Growth Differ; 1997 Dec; 8(12):1243-7. PubMed ID: 9419412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
    Neary CL; Cho-Chung YS
    Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
    Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K
    J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
    Nesterova M; Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.